CD8A and neoplasm: Since activated CD8+ lymphocytes can directly kill tumor cells and play an essential role in anti-tumor immunity, the combination of neoadjuvant chemotherapy and radiotherapy with immunotherapy may enhance the T cell-dependent antitumor response [49].